Full-Time

Pharmacy Manager

Posted on 10/4/2025

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$109.3k - $182.1k/yr

+

Orlando, FL, USA + 3 more

More locations: Kissimmee, FL, USA | Melbourne, FL, USA | Port St. Lucie, FL, USA

In Person

Travel up to 5% of the time, within-state and out-of-state.

Category
Medical, Clinical & Veterinary (3)
, ,
Requirements
  • Graduate of an accredited school of pharmacy.
  • Current, active Pharmacy license as granted by the State Board of Pharmacy.
  • At least 5 to 7 years of experience in a clean room or infusion pharmacy setting OR 3 years of experience and one of the following: (a) knowledge of non-sterile compounding, and MTM (b) completion of an ASHP accredited Pharmacy Residency Program, or (c) equivalent experience as approved by the VP of Pharmacy and/or SVP of Clinical Services.
  • At least 3 years of experience directly managing people, including hiring, developing, motivating, and directing people as they work.
  • At least 2 years of experience planning, developing, and managing departmental expense and capital budgets or completion of an ASHP accredited Residency Program or equivalent experience as approved by the National Director of Pharmacy and/or VP of Clinical Services.
  • Experience compounding sterile products and managing patient care.
  • Experience overseeing purchasing and inventory process of all pharmaceutical and related substances and supplies.
  • Access to a reliable means of transportation which will enable the incumbents to make home visits to treat/attend to their patients. If such means of transportation would include a personal vehicle, a valid driver’s license and a proof of insurance would be required.
  • Active membership in a related state or national clinical, pharmaceutical, or home health care organization.
  • Experience in identifying operational issues and recommending and implementing strategies to resolve problems.
  • Experience providing customer service to internal and external customers, including meeting quality standards for services, and evaluation of customer satisfaction.
  • Basic level skill in Microsoft Word.
  • Basic level skill in Microsoft Excel.
  • Basic skill level in Microsoft PowerPoint.
  • Willing to travel up to 5 % of the time for business purposes. (Within state and out of state).
Responsibilities
  • Determines suitability of patients for home care. Supervises, monitors and evaluates the quality and effectiveness of patient care provided by pharmacy staff. Manages daily activities with regards to effective operations and communications.
  • Directs the activities of the pharmacy department. Schedules work activities of pharmacy staff so that the pharmaceutical-care needs of the patients are met.
  • Develops and mentors staff through on-boarding, open communication, training and development opportunities and performance management processes.
  • Oversees product purchasing, inventory, budget and equipment management. Assists the General Manager in preparing, securing approval for, and implementing operating and expenditure budgets for department, and operates within those guidelines. Evaluates and oversees the purchase, management and security of all medications, pumps and medical supplies in accordance with the Option Care policies and formulary guidelines.
  • Provides support to sales professionals and general manager by speaking knowledgeably of the scope of services that are available through Option Care. Description of available services is accurate. Meets with managed care organizations and other accounts to facilitate education regarding available services.
  • May serve as the Office Administrator with the Director of Nursing or Nurse Manager in the absence of the General Manager. Collects and organizes all patient-specific information needed to prevent, detect, and resolve medication-related problems and to make appropriate medication therapy recommendations.
  • Monitors the clinical staff’s documentation on pharmacy care plans for home care patients based on evaluation of monitoring data and other pertinent patient-specific information.
  • Evaluates competency in the use of pharmacokinetic principles and formulas and competency.
  • Ensures that medications are prepared and dispensed using appropriate techniques and following Option Care’ policies and procedures. Equipment is accurately calibrated. Medications are prepared so they are appropriately concentrated, without incompatibilities, stable, and appropriately stored.
  • Coordinates and participates in on-call responsibilities of the pharmacy department. Ensures reliable pharmacy coverage for on-call activities. Provides reliable pharmacy services when scheduled to be on-call.
  • Manages the use of investigational drug products according to established regulations and Option Care policies and procedures. In all activities, complies with accreditation, legal, regulatory, and safety requirements.
Desired Qualifications
  • Post-graduate residency program in clinical pharmacy services.
  • Board certification in Nutrition Support Pharmacy, Pharmacotherapy or other clinical pharmacy practice area.
  • Experience managing inventory and logistics.
  • At least 5 years of experience compounding sterile products and managing complex infusion patients.
  • At least 3 years of experience overseeing purchasing and inventory process of all pharmaceutical and related substances and supplies.

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Simplify Jobs

Simplify's Take

What believers are saying

  • Analyst price targets up to $40.09 suggest 46% upside from May levels.
  • Expanded $850M credit facility enables M&A consolidation in fragmented market.
  • Management projects $7B revenue by 2029 assuming CID reset normalizes.

What critics are saying

  • Chronic Inflammatory Disease portfolio headwind of $55M persists beyond 2026.
  • Revenue growth slowed to 1.1% versus historical 12% and industry 4.7%.
  • Biosimilar conversions and IRA headwinds compress margins $25–35M annually through 2027.

What makes Option Care Health unique

  • Largest independent home infusion provider with 315,000+ unique patients served.
  • 40% of claims processed without human intervention via automation investments.
  • Diversified portfolio across acute, chronic, and immunoglobulin neurology therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Simply Wall St
Apr 4th, 2026
Option Care Health expands credit facility to $850M, boosts buyback to $1B

Option Care Health has expanded its revolving credit facility by $450 million to $850 million and increased its share repurchase authorisation to $1 billion, whilst reaffirming its 2026 guidance. The moves strengthen liquidity and signal management confidence in cash generation. The expanded buyback and credit facility provide greater flexibility for growth investments and capital returns, though near-term focus remains on executing guidance and managing reimbursement pressures. The company's narrative projects $7 billion revenue and $302.2 million earnings by 2029, implying 7.5% annual revenue growth. Analyst fair value estimates range widely from $3.66 to $40.09 per share, with the upper estimate suggesting 46% upside from current prices.

MicroCare
Mar 9th, 2026
MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare.

MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare. March 09, 2026 MicroCare Medical is pleased to welcome Matt Lingenfelter as national sales manager, healthcare. With more than 20 years of experience in healthcare sales and leadership, Matt will help drive national growth and strengthen partnerships for the MicroCare Medical instrument care and infection prevention solutions. In this role, Matt will guide healthcare sales strategy across the U.S., focusing on expanding key accounts, building strong distributor relationships, and supporting the sales team. He will also work closely with marketing, operations, and product development to ensure MicroCare continues delivering solutions that meet the evolving needs of healthcare professionals. Before joining MicroCare, Matt held leadership roles with Option Care Health, Belimed, and Aesculap, where he developed deep expertise in surgical instrumentation, endoscopic technologies, and hospital system support. "Matt's experience and understanding of healthcare systems make him a fantastic addition to our team," said Ray Bellavance, vice president of global sales and marketing at MicroCare. "We're excited to have him help grow our healthcare business and strengthen partnerships across the country."

Yahoo Finance
Feb 27th, 2026
Option Care Health posts 13% revenue growth despite $25M–35M Stelara biosimilar headwind

Option Care Health reported a 13% revenue increase in Q4 2025, with acute therapies growing in the mid-teens and chronic therapies in the low double digits. The company served over 315,000 unique patients and improved operational efficiency, with 40% of claims now processed without human intervention. For 2026, the company issued revenue guidance of $5.8 billion to $6 billion, incorporating a 400 basis point headwind from Stelara biosimilar conversions and Inflation Reduction Act impacts. Adjusted EBITDA is projected at $480 million to $505 million, accounting for a $25 million to $35 million gross profit headwind from Stelara transitions. Operating cash flow is expected to exceed $340 million, representing over 30% growth. The company plans to launch at least two new pharmaceutical manufacturer programmes and expand its infusion clinic model to support higher-acuity therapies.

PREEMPT, Inc
Sep 30th, 2025
EEOC Sues Option Care Health, Inc. for Pregnancy Discrimination

EEOC sues Option Care Health, Inc. for pregnancy discrimination.

Option Care Health
Aug 7th, 2025
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

Quince Therapeutics selects Option Care Health as specialty infusion therapy provider for administration of lead asset eDSP.

INACTIVE